According to a nationwide study, the estimated crude prevalence of MS in Japan in 2003 was 7.7 (95% confidence interval [CI], 7.1–8.4) per 100,000 population, with an increasing trend over time [ 2 ].
← all excerpts
Interleukin-6: evolving role in the management of neuropathic pain in neuroimmunological disorders.
1
—
—